Drug Shortage Report for DULOXETINE
| Report ID | 202687 |
| Drug Identification Number | 02490889 |
| Brand name | DULOXETINE |
| Common or Proper name | DULOXETINE |
| Company Name | SANIS HEALTH INC |
| Market Status | DORMANT |
| Active Ingredient(s) | DULOXETINE |
| Strength(s) | 30MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-08-22 |
| Estimated end date | 2024-01-22 |
| Actual end date | 2024-01-22 |
| Shortage status | Resolved |
| Updated date | 2024-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.